Circa Group AS (OSL:CIRCA)

Market Cap	77.70M
Revenue (ttm)	13.55M
Net Income (ttm)	-83.83M
Shares Out	121.78M
EPS (ttm)	-0.70
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.6380
Previous Close	0.6380
Day's Range	0.6380 - 0.6380
52-Week Range	0.3300 - 3.7900
Beta	-0.10
RSI	54.25
Earnings Date	Dec 6, 2024

About Circa Group AS

Circa Group AS engages in the production and sale of biochemicals in Australia, France, the United Kingdom, Belgium, and Norway. The company extracts value from non-food waste biomass to produce bio-based chemicals through its Furacell production process. Its products include Cyrene, a polar aprotic solvent; and Levoglucosenone derivatives. The company’s products are used in pharmaceuticals, agrochemicals, flavors, fragrances, electronics, batteries, paints, graphene, polymers, and other applications. Circa Group AS was founded in 2006 and is h...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 17
• Stock Exchange: Oslo Børs
• Ticker Symbol: CIRCA

Financial Performance

In 2023, Circa Group AS's revenue was 1.68 million, an increase of 41.77% compared to the previous year's 1.19 million. Losses were -5.98 million, 0.05% more than in 2022.

Financial numbers in EUR